Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.470
+0.010 (0.29%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Clover Health Investments Revenue
In the year 2024, Clover Health Investments had annual revenue of $1.37B with 8.52% growth. Clover Health Investments had revenue of $336.96M in the quarter ending December 31, 2024, with 9.28% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+8.52%
P/S Ratio
1.24
Revenue / Employee
$2,404,674
Employees
570
Market Cap
1.77B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
CLOV News
- 2 days ago - Clover Health Announces Changes to Board of Directors - GlobeNewsWire
- 3 days ago - Clover Health to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025 - GlobeNewsWire
- 17 days ago - Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage - GlobeNewsWire
- 6 weeks ago - Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth - Seeking Alpha
- 7 weeks ago - Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians - GlobeNewsWire
- 2 months ago - Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance - GlobeNewsWire